Date Filed | Type | Description |
10/05/2023 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 755 shares
@ $1.9763, valued at
$1.5k
|
|
08/21/2023 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 10,516 shares
@ $2.4955, valued at
$26.2k
|
|
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2023 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 2,983 shares
@ $3.0451, valued at
$9.1k
|
|
04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/23/2023 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 5,111 shares
@ $5.0777, valued at
$26k
Sold 1,426 shares
@ $5.1438, valued at
$7.3k
|
|
10/26/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2022 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 100,000 shares
@ $0 |
|
08/01/2022 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 3,253,796 shares
@ $4.61, valued at
$15M
|
|
07/21/2022 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 1,432 shares
@ $5.2145, valued at
$7.5k
|
|
07/06/2022 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 29,400 shares
@ $0 Granted 54,600 options to buy
@ $4.13, valued at
$225.5k
|
|
04/29/2022 |
4
| Sinha Vikas (Director) has filed a Form 4 on Verona Pharma plc
Txns:
| Granted 200,000 options to buy
@ $0 |
|
04/22/2022 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 1,162 shares
@ $6.6843, valued at
$7.8k
|
|
04/04/2022 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 48,838 shares
@ $0 Granted 119,162 options to buy
@ $9.15, valued at
$1.1M
|
|
01/24/2022 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 6,450 shares
@ $8.7526, valued at
$56.5k
|
|
08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/22/2020 |
3
| Sinha Vikas (Director) has filed a Form 3 on BCLS Acquisition Corp. |
08/05/2020 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Converted 13,420,970 shares
@ $0 Converted 20,000,000 convertible preferred
@ $0 |
|
07/31/2020 |
4
| Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 436,900 options to buy
@ $17, valued at
$7.4M
|
|
07/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
08/10/2016 |
4
| Sinha Vikas (EVP & CFO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 277 shares
@ $137.14, valued at
$38k
|
|
03/01/2016 |
4
| Sinha Vikas (EVP & CFO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 Sold 1,120 shares
@ $138.91, valued at
$155.6k
Sold 2 shares
@ $141.23, valued at
$282.5 Granted 31,000 options to buy
@ $140.16, valued at
$4.3M
|
|
02/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/30/2013 |
4
| Sinha Vikas (EVP & CFO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 42,138 shares
@ $122.8, valued at
$5.2M
Sold 7,862 shares
@ $123.85, valued at
$973.7k
Exercised 50,000 options to buy
@ $17.65, valued at
$882.5k
|
|
08/07/2013 |
4
| Sinha Vikas (EVP & CFO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 852 shares
@ $116.87, valued at
$99.6k
|
|
08/01/2013 |
4
| Sinha Vikas (EVP & CFO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 995 shares
@ $110.86, valued at
$110.3k
|
|
07/16/2013 |
4
| Sinha Vikas (EVP & CFO) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 50,000 shares
@ $120, valued at
$6M
Exercised 37,496 options to buy
@ $11.92, valued at
$447k
Exercised 12,504 options to buy
@ $17.65, valued at
$220.7k
|
|
|